Search

Search Constraints

You searched for: Author/Creator Bilgin, Yavuz M.

Search Results

1. Evaluation of Dutch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor. Issue 5 (30th December 2014)

2. Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. Issue 11 (25th November 2022)

3. Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study. Issue 25 (1st September 2021)

4. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. (April 2023)

5. Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report. Issue 8 (28th June 2022)

7. Rituximab‐PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study. (10th July 2019)

8. Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma. (15th May 2019)